Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance Paclitaxel Vs Control After Anthracycline/Paclitaxel Combined First-Line Chemotherapy in Metastatic Breast Cancer

NCT00289263 is registered in ClinicalTrials.gov with MANTA 1 Study Italian Collaborative Group as lead sponsor.

NCT NCT00289263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance Paclitaxel Vs Control After Anthracycline/Paclitaxel Combined First-Line Chemotherapy in Metastatic Breast Cancer
Lead sponsor
MANTA 1 Study Italian Collaborative Group
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 1998
Completion date
October 31, 2003
Enrollment
524
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer